POLYMED

Poly Medicure LimitedNSE
₹1,730.1+29.00 (+1.70%)

Market Closed · NSE · INR

Open

₹1,700.3

High

₹1,751

Low

₹1,682.3

Prev Close

₹1,701.1

52-Week Range60% from low
₹1,191.1
₹2,085.4

Market Cap

₹17.24 K Cr

Mid Cap

P/E (TTM)

54.72

EPS

₹31.09

Div Yield

0.41%

P/B Ratio

5.57

ROE

9.9%

Key Metrics

Forward P/E34.86
Book Value₹310.69
Debt/Equity0.11×
Revenue Growth30.3%
Profit Margin15.67%
Operating Margin23.59%
Volume1.27 L
Avg Volume (20d)2.53 L
Delivery %39.62%
Trades13,443

Analyst Ratings(6 analysts)

-

Target Price

₹1,825

+5.5% upside

Strong Buy2
Buy2
Hold1
Strong Sell1
Low: ₹1,400Median: ₹1,866High: ₹2,240

Current price: ₹1,730

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareMedical Instruments & Supplies

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access...

polymedicure.com2,614 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 7.00/share
23
24
25
26
28 Aug 20263.50
18 Sept 20253.50
19 Sept 20243.00
21 Sept 20233.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.